Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer

Withdrawn before enrolling · Phase 1 · Has a placebo group

Conditions studied: Pancreatic Cancer, Cholangiocarcinoma

In brief

Investigation of the effects of daily sildenafil on patients with pancreatic or cholangiocarcinoma cancer undergoing treatment.

Key facts

Study ID
NCT02106871
Run by
The University of Texas Medical Branch, Galveston
People needed
0
Starts
2014-04-01
Expected to finish
2017-06-01
Last updated by the study team
2017-10-27

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.